Diverse mechanisms of PARP inhibitor resistance in ovarian cancer

被引：18
|
作者：
Wakefield, Matthew John [1 ,2 ]
Nesic, Ksenija [1 ,3 ]
Kondrashova, Olga [4 ]
Scott, Clare L. [1 ,2 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
[4] QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2019年 / 1872卷 / 02期
基金：
英国医学研究理事会;
关键词：
REPLICATION FORK REVERSAL; CELL-FREE DNA; HOMOLOGOUS RECOMBINATION; MRE11-DEPENDENT DEGRADATION; GERMLINE MUTATIONS; EXCISION-REPAIR; MUTANT-CELLS; NASCENT DNA; BRCA2; STABILITY;
D O I：
10.1016/j.bbcan.2019.08.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Novel mechanisms of PARP inhibitor resistance
    D'Andrea, Alan D.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [12] Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
    Ray-Coquard, Isabelle
    Vanacker, Helene
    Le Saux, Olivia
    Tredan, Olivier
    [J]. EBIOMEDICINE, 2020, 61
  • [13] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Kim, Hyoung
    Xu, Haineng
    George, Erin
    Hallberg, Dorothy
    Kumar, Sushil
    Jagannathan, Veena
    Medvedev, Sergey
    Kinose, Yasuto
    Devins, Kyle
    Verma, Priyanka
    Ly, Kevin
    Wang, Yifan
    Greenberg, Roger A.
    Schwartz, Lauren
    Johnson, Neil
    Scharpf, Robert B.
    Mills, Gordon B.
    Zhang, Rugang
    Velculescu, Victor E.
    Brown, Eric J.
    Simpkins, Fiona
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [14] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Hyoung Kim
    Haineng Xu
    Erin George
    Dorothy Hallberg
    Sushil Kumar
    Veena Jagannathan
    Sergey Medvedev
    Yasuto Kinose
    Kyle Devins
    Priyanka Verma
    Kevin Ly
    Yifan Wang
    Roger A. Greenberg
    Lauren Schwartz
    Neil Johnson
    Robert B. Scharpf
    Gordon B. Mills
    Rugang Zhang
    Victor E. Velculescu
    Eric J. Brown
    Fiona Simpkins
    [J]. Nature Communications, 11
  • [15] PARP inhibitor nanotherapy for ovarian cancer
    Baldwin, Paige
    Ohman, Anders
    Thong, Jeremy
    Tangutoori, Shifalika
    Dinulescu, Daniela
    Sridhar, Srinivas
    [J]. CLINICAL CANCER RESEARCH, 2016, 22
  • [16] Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
    Paola Francica
    Sven Rottenberg
    [J]. Genome Medicine, 10
  • [17] Glutamine metabolism drives some mechanisms of PARP inhibitor persistence in ovarian cancer
    Herrera, Adriana Del Pino
    Ferrall-Fairbanks, Meghan
    Damaghi, Mehdi
    Song, Joon-Hyun
    Kanadibhotla, Snigdha
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [18] Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment
    Jackson, Lindsey M.
    Moldovan, George-Lucian
    [J]. NAR CANCER, 2022, 4 (04):
  • [19] Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
    Francica, Paola
    Rottenberg, Sven
    [J]. GENOME MEDICINE, 2018, 10
  • [20] Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients
    Senturk Kirmizitas, Tugce
    van den Berg, Caroline
    Boers, Ruben
    Helmijr, Jean
    Makrodimitris, Stavros
    Dag, Hamit Harun
    Kerkhofs, Marijn
    Beaufort, Corine
    Kraan, Jaco
    van IJcken, Wilfred F. J.
    Gribnau, Joost
    Garkhail, Pakriti
    Boer, Gatske Nieuwenhuyzen-de
    Roes, Eva-Maria
    van Beekhuizen, Heleen
    Gunel, Tuba
    Wilting, Saskia
    Martens, John
    Jansen, Maurice
    Boere, Ingrid
    [J]. GENES, 2024, 15 (06)
12345